IDSA Foundation

What IDSA Foundation does

IDSA Foundation is a 501(c)(3) nonprofit charitable organization (EIN 31-1765388) that operates as the dedicated philanthropic arm of the Infectious Diseases Society of America (IDSA), headquartered at 4040 Wilson Blvd., Suite 300, Arlington, Virginia. The foundation's mandate is to fundraise in support of IDSA's strategic priorities: strengthening the infectious diseases workforce, advancing inclusion and health equity in the ID field, and enhancing IDSA's capacity to lead in preparedness, research, and public health response. It serves three primary beneficiary segments — early-career ID professionals seeking mentorship and travel grants, practicing ID clinicians seeking continuing medical education, and underrepresented professionals in ID seeking growth opportunities — and is the institutional home of the Save HIV Funding advocacy coalition (founded 2023 with PrEP4All, AVAC, and HIVMA).

The foundation's product surface is a portfolio of programs rather than technology products. iDMentorship365 matches medical students, residents, and fellows with experienced ID mentors. IDWeek is the flagship annual ID conference co-hosted with IDSA and related societies. The Dr. John G. Bartlett Memorial Webinar Series delivers recurring virtual education on evolving ID topics such as the COVID-19 vaccine landscape. Workforce development includes travel grants for early-career professionals, while the Save HIV Funding Campaign (launched 2023) coordinates 150+ advocacy organizations and, per the foundation, helped stop nearly $2 billion in federal HIV funding cuts in fiscal year 2026. The foundation holds a Candid Platinum Seal of Transparency through 2026.

Revenue mechanics are split between individual philanthropic donations (one-time and recurring, processed through an integrated GoFundMe donation platform on idsafoundation.org and tax-deductible under U.S. law) and corporate/industry partnerships. The 2026 Industry Partners program lists 14 named sponsors: AbbVie, CSL Seqirus, AstraZeneca, Bayer, Gilead Sciences, GSK, Merck, Moderna, Novartis, Pfizer, QuidelOrtho, Sanofi, Shionogi, and ViiV Healthcare. Go-to-market is event-driven (IDWeek, Bartlett Series, iDMentorship365) and community-led, with marketing distributed across the ID Insights email newsletter, six social platforms (LinkedIn, Facebook, Instagram, Twitter/X, Threads, BlueSky), podcasts, and the foundation website. Financial figures — total contributions, headcount, and program-level budgets — are not publicly disclosed.

Name

IDSA Foundation

Legal name

IDSA Foundation

Website

https://idsafoundation.org

Company type

Private

Operating status

Operating

Short description

IDSA Foundation is the 501(c)(3) charitable arm of the Infectious Diseases Society of America, funding ID workforce development, mentorship, continuing education, and health equity programs through individual donations and a 14-partner pharmaceutical industry sponsorship program.

Ownership category

akta.pro rank

Product category

Nonprofit Healthcare Foundation - Infectious Diseases Professional Development

NAICS

Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Infectious Disease & Immunization Program Funding (HLAJALAH)

Keywords

• Infectious diseases education
• ID workforce development
• Medical mentorship programs
• Health equity advocacy
• HIV funding coalition

Headquarters

HQ city

Arlington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Philanthropic Donations: Individual donors contribute tax-deductible gifts to support ID workforce development, mentorship programs, and health equity initiatives. Donations can be one-time or recurring (monthly).
2. Corporate/Industry Partnerships: Pharmaceutical and healthcare companies partner with the foundation through sponsorship arrangements, including 14 named industry partners in 2026 (AbbVie, CSL Seqirus, AstraZeneca, Bayer, Gilead, GSK, Merck, Moderna, Novartis, Pfizer, QuidelOrtho, Sanofi, Shionogi, ViiV Healthcare).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

IDSA Foundation is the 501(c)(3) charitable arm of the Infectious Diseases Society of America, operating philanthropic programs that strengthen the ID workforce. Core offerings include the iDMentorship365 mentorship program connecting medical students, residents, and fellows with experienced ID mentors; travel grants and career development support for early-career professionals; the Dr. John G. Bartlett Memorial Webinar Series; and health equity initiatives for underrepresented professionals. The foundation is funded by tax-deductible individual donations and corporate industry partnerships with pharmaceutical and healthcare companies.

Product overview

IDSA Foundation is a 501(c)(3) charitable organization that serves as the primary fundraising partner of the Infectious Diseases Society of America. Rather than offering a unified technology product, the Foundation provides a portfolio of programs and initiatives including the iDMentorship365 mentorship program, the Bartlett Memorial Webinar Series, IDWeek annual conference, ID workforce development with travel grants, health equity initiatives, and the Save HIV Funding advocacy campaign. These offerings work together to strengthen the ID workforce, promote inclusion and diversity, and enhance IDSA's capacity in preparedness, research, and public health response.

Differentiator

Problem solved

Functional benefit

Products and services

• iDMentorship365 A mentorship program that connects medical students, residents, and fellows with experienced infectious diseases mentors and career resources to develop their passion for the ID specialty. Targeted at early-career ID professionals seeking career guidance.
• IDWeek Annual Conference Annual conference bringing together infectious diseases professionals for education, networking, and research presentations. Targeted at ID clinicians, researchers, and healthcare professionals.
• Dr. John G. Bartlett Memorial Webinar Series A named webinar series featuring educational content on evolving topics in infectious diseases, such as COVID-19 vaccine landscapes. Targeted at ID clinicians seeking continuing medical education.
• Save HIV Funding Campaign A coalition advocacy campaign launched in 2023 with PrEP4All and AVAC (and HIVMA) to protect federal HIV program funding and mobilize advocacy efforts against program cuts. Targeted at policymakers and the broader HIV advocacy community.

Quantifiable outcome

• Educates 1,000+ clinicians annually on timely ID care topics
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

19 partnerships are on record, tiered core.

• AbbViecoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• CSL SeqiruscoreGTM or Marketing Partner · 1 January 2026Vaccine company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• AstraZenecacoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• BayercoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• Gilead SciencescoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner specializing in HIV and viral diseases, supporting the IDSA Foundation's 2026 Industry Partnership program and related initiatives.
• GSKcoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• MerckcoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• ModernacoreGTM or Marketing Partner · 1 January 2026Biotechnology company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• NovartiscoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• PfizercoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• QuidelOrthocoreGTM or Marketing Partner · 1 January 2026Diagnostics company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• SanoficoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• ShionogicoreGTM or Marketing Partner · 1 January 2026Pharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
• ViiV HealthcarecoreGTM or Marketing Partner · 1 January 2026Specialty pharmaceutical company focused on HIV, partnered with the IDSA Foundation's 2026 Industry Partnership program supporting ID workforce and health equity initiatives.
• PrEP4AllcoreStrategic or Co-development Partner · 1 January 2023Co-founder of the Save HIV Funding campaign along with AVAC and HIVMA. The campaign has grown to 150+ organizations and stopped nearly $2 billion in HIV funding cuts.
• AVACcoreStrategic or Co-development Partner · 1 January 2023Co-founder of the Save HIV Funding campaign along with PrEP4All and HIVMA. Campaign focuses on protecting federal HIV program funding.
• HIVMAcoreStrategic or Co-development Partner · 1 January 2023Co-founder of the Save HIV Funding campaign along with PrEP4All and AVAC. Joint fundraising effort with IDSA Foundation to protect federal HIV funding.
• IDSA (Infectious Diseases Society of America)coreStrategic or Co-development PartnerThe foundation is the 501(c)(3) charitable arm of IDSA and serves as the primary fundraising partner advancing IDSA's strategic priorities.
• IDWeekcoreStrategic or Co-development PartnerAnnual ID conference co-hosted/associated with the foundation, providing platform for education and foundation engagement.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key highlights6 records

Customer concentration

• Xtwitter.com/idsainfo
• Facebookfacebook.com/IDSociety
• LinkedInlinkedin.com/company/idsociety
• Instagraminstagram.com/idsainfo

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDSA Foundation